Treatment of neurodegenerative conditions
BTG International Ltd (2010) Treatment of neurodegenerative conditions. US2010/0113810 A1.Full text not available from this repository.
A method is provided for treating a patient in need of therapy for a neurodegenerative disease comprising administering to that patient a therapeutically effective dose of a lipid glyceride comprising a glycerol moiety and a fatty acid moiety, the fatty acid moiety being selected from the group consisting of γ-linolenic acid, dihomo-γ-linolenic acid and arachidonic acid characterised in that the selected fatty acid moiety is attached to the glycerol moiety at its sn-2 position. Preferably the method is that wherein the lipid is administered for a duration and at a dose sufficient to maintain or elevate TGF-β1 levels in the patient to therapeutic levels.
|Uncontrolled Keywords:||polyunsaturated fatty acids, treatment of multiple sclerosis|
|Subjects:||R Medicine > R Medicine (General)|
|Faculty / Department / Research Groups:||Faculty of Engineering & Science > Department of Life & Sports Sciences|
|Last Modified:||05 Dec 2016 12:27|
Actions (login required)